251 related articles for article (PubMed ID: 19327989)
1. Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
Humphries PS; Lafontaine JA; Agree CS; Alexander D; Chen P; Do QQ; Li LY; Lunney EA; Rajapakse RJ; Siegel K; Timofeevski SL; Wang T; Wilhite DM
Bioorg Med Chem Lett; 2009 Apr; 19(8):2099-102. PubMed ID: 19327989
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
Alam M; Beevers RE; Ceska T; Davenport RJ; Dickson KM; Fortunato M; Gowers L; Haughan AF; James LA; Jones MW; Kinsella N; Lowe C; Meissner JW; Nicolas AL; Perry BG; Phillips DJ; Pitt WR; Platt A; Ratcliffe AJ; Sharpe A; Tait LJ
Bioorg Med Chem Lett; 2007 Jun; 17(12):3463-7. PubMed ID: 17459703
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies.
Liu M; Wang S; Clampit JE; Gum RJ; Haasch DL; Rondinone CM; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
Bioorg Med Chem Lett; 2007 Feb; 17(3):668-72. PubMed ID: 17107797
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3.
Swahn BM; Huerta F; Kallin E; Malmström J; Weigelt T; Viklund J; Womack P; Xue Y; Ohberg L
Bioorg Med Chem Lett; 2005 Nov; 15(22):5095-9. PubMed ID: 16140012
[TBL] [Abstract][Full Text] [Related]
6. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
Hom RK; Bowers S; Sealy JM; Truong AP; Probst GD; Neitzel ML; Neitz RJ; Fang L; Brogley L; Wu J; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Quinn K; Sauer JM; Powell K; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
Bioorg Med Chem Lett; 2010 Dec; 20(24):7303-7. PubMed ID: 21071223
[TBL] [Abstract][Full Text] [Related]
8. Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
Gong L; Han X; Silva T; Tan YC; Goyal B; Tivitmahaisoon P; Trejo A; Palmer W; Hogg H; Jahagir A; Alam M; Wagner P; Stein K; Filonova L; Loe B; Makra F; Rotstein D; Rapatova L; Dunn J; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Hermann J; Kuglstatter A; Goldstein D
Bioorg Med Chem Lett; 2013 Jun; 23(12):3565-9. PubMed ID: 23664880
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
[TBL] [Abstract][Full Text] [Related]
10. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
Liu M; Xin Z; Clampit JE; Wang S; Gum RJ; Haasch DL; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
Bioorg Med Chem Lett; 2006 May; 16(10):2590-4. PubMed ID: 16527482
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.
Noël R; Shin Y; Song X; He Y; Koenig M; Chen W; Ling YY; Lin L; Ruiz CH; LoGrasso P; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 May; 21(9):2732-5. PubMed ID: 21185177
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitors.
Arnold DM; Foster C; Huryn DM; Lazo JS; Johnston PA; Wipf P
Chem Biol Drug Des; 2007 Jan; 69(1):23-30. PubMed ID: 17313454
[TBL] [Abstract][Full Text] [Related]
14. Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
Das J; Moquin RV; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly K; Doweyko AM; Sack JS; Zhang H; Kiefer SE; Kish K; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
Bioorg Med Chem Lett; 2008 Apr; 18(8):2652-7. PubMed ID: 18359226
[TBL] [Abstract][Full Text] [Related]
15. Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR.
Richardson CM; Williamson DS; Parratt MJ; Borgognoni J; Cansfield AD; Dokurno P; Francis GL; Howes R; Moore JD; Murray JB; Robertson A; Surgenor AE; Torrance CJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1353-7. PubMed ID: 16325401
[TBL] [Abstract][Full Text] [Related]
16. Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
Selness SR; Devraj RV; Monahan JB; Boehm TL; Walker JK; Devadas B; Durley RC; Kurumbail R; Shieh H; Xing L; Hepperle M; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R
Bioorg Med Chem Lett; 2009 Oct; 19(20):5851-6. PubMed ID: 19751974
[TBL] [Abstract][Full Text] [Related]
17. 3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors.
Jiang R; Duckett D; Chen W; Habel J; Ling YY; LoGrasso P; Kamenecka TM
Bioorg Med Chem Lett; 2007 Nov; 17(22):6378-82. PubMed ID: 17911023
[TBL] [Abstract][Full Text] [Related]
18. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
[TBL] [Abstract][Full Text] [Related]
19. Identification of c-Jun N-terminal kinase as a therapeutic target for abdominal aortic aneurysm.
Yoshimura K; Aoki H; Ikeda Y; Furutani A; Hamano K; Matsuzaki M
Ann N Y Acad Sci; 2006 Nov; 1085():403-6. PubMed ID: 17182964
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.
Kamenecka T; Jiang R; Song X; Duckett D; Chen W; Ling YY; Habel J; Laughlin JD; Chambers J; Figuera-Losada M; Cameron MD; Lin L; Ruiz CH; LoGrasso PV
J Med Chem; 2010 Jan; 53(1):419-31. PubMed ID: 19947601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
